rs2072661 risk_factor_for quitting
Evidence from:
primary |
all sources
Evidence (2 sources)
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.
(2008)
PMID:18593715
cited
At 6‑months follow‑up, the genetic effect for rs2072661 becomes more pronounced (OR = 0.31; 95% CI 0.18–0.55; P = 0.00006)
confidence: 0.96
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.
(2008)
PMID:18593715
cited
For those individuals who received bupropion, the impact of rs2072661 was substantial for decreasing the odds of quitting (OR = 0.25; 95% CI 0.08–0.78).
confidence: 0.90